# ZD 1839 in Treating Patients With Metastatic or Recurrent Cancer of the Head and Neck

> **NCT00015964** · PHASE2 · COMPLETED · sponsor: **University of Chicago** · enrollment: 51 (actual)

## Conditions studied

- Head and Neck Cancer

## Interventions

- **DRUG:** ZD1839

## Key facts

- **NCT ID:** NCT00015964
- **Lead sponsor:** University of Chicago
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-03
- **Primary completion:** 2001-09
- **Final completion:** 2005-07
- **Target enrollment:** 51 (ACTUAL)
- **Last updated:** 2013-09-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00015964

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00015964, "ZD 1839 in Treating Patients With Metastatic or Recurrent Cancer of the Head and Neck". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00015964. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*